Effects of neuregulins on invasion and metastasis of non-overexpression ErbB2 breast cancer cells
- 48 Downloads
Abstract
Objective
To explore the effects of neuregulins on ErbB2 receptor signal transduction pathway activation, and invasion and metastasis of non-overexpression ErbB2 breast cancer cell MDA-MB-231.
Methods
The expressions of neuregulin were detected by immunocytochemistry and Western blot. MDA-MB-231 cells were treated with ErbB2 kinase inhibitor AG825. Proliferations were measured with MTT assay. Invasion and metastasis of MDA-ME-231 cells were evaluated with transwell chamber. The enzyme activities of MMP-2 and MMP-9 were detected by gelatin zymography. The expressions of MMP-2 and HIF-1α were detected by Western blot.
Results
MDA-MB-231 cells expressed a relatively higher level of neuregulin. In Western blot, the positive reaction band was found at 44KD which coincides with the molecular weight of NRG. When MDA-MB-231 cells were treated with AG825, the proliferation was inhibited in a time-dose-dependent manner (P<0.01), invasion and metastasis were also depressed (P<0.05). The enzyme activities of MMP-2 and MMP-9 were lower (P<0.05). The expression levels of MMP-2 and HIF-1α were decreased (P<0.05).
Conclusion
Our study indicates that neuregulins are synthesized in MDA-MB-231 cells as transmembrane proteins, neuregulins could activate ErbB2 receptor signal transduction pathway by autocrine or paracrine secretion, and induce invasion and metastasis of MDA-MB-231 cells.
Key words
Non-overexpression ErbB2 breast cancer Neuregulins Invasion MetastasisCLC number
R737.9Preview
Unable to display preview. Download preview PDF.
References
- [1]Cuiling Ma, Hong Lin, Stephen S, et al. Overexpress of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro [J]. Oncogene 2003; 22:5281–5290.CrossRefGoogle Scholar
- [2]Fabao Tang, Yong Xia. Effect of Overexpression C-erbB2 to Selecting Postoperative Chemotherapy Regimen of Breast Cancer Cell [J]. Chin Gen Surg(in Chinese) 2006; 21:901–902.Google Scholar
- [3]Douglas L, Falls. Neuregulins: functions, forms, and signaling strategies [J]. Experi Cell Res 2003; 284:14–30.CrossRefGoogle Scholar
- [4]M. S. Tsai, Lisa A, Shamon-Taylor, et al. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer [J]. Oncogene 2003; 22:761–768.PubMedCrossRefGoogle Scholar
- [5]Marshall C, Blackburn E, Clark M, et al. Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma in situ of the human breast [J]. Breast Cancer Res Treat 2006; 96:163–168.PubMedCrossRefGoogle Scholar
- [6]Yuste L, Montero JC, Esparis-Ogando A, et al. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin [J]. Cancer Res 2005; 65:6801–6810.PubMedCrossRefGoogle Scholar
- [7]Khaleque MA, Bhari A, Sawyer D, et al. Induction of heat shock proteins by heregulin betal leads to protection from apoptosis and anchorage -independent growth [J]. Oncogene 2005; 24:6564–6573.PubMedGoogle Scholar
- [8]Vellon L, Menendez JA, Lupu R. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer [J]. Oncogene 2005; 24:3759–3773.PubMedCrossRefGoogle Scholar
- [9]Amin DN, Tuck D, Stern DF, et al. Neuregulinregulated gene expression in mammary carcinoma cells [J]. Exp Cell Res 2005; 309:12–23.PubMedCrossRefGoogle Scholar
- [10]Aguilar Z, Dennis J. Slamon. The transmembrane heregulin precursor is functional active [J]. Bio Chem 2001; 276:44099–44107.CrossRefGoogle Scholar
- [11]Li Q, Ahmed S, Loeb JA. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells [J]. Cancer Res 2004; 64:7078–7085.PubMedCrossRefGoogle Scholar
- [12]Murillo H, Schmidt LJ, Tindall, DJ. Tyrphostin AG825 trigger p38 mitogen-activatied protein kinase-dependent apoptosis in androgen- independent prostate cancer cells C4 and C4-2 [J]. Cancer Res 2001; 61:7408–7412.PubMedGoogle Scholar
- [13]Breuleux M, Schoumacher F, Rehn D, et al. Heregulins Implicted in Cellular Functions Other Than Receptor Activation [J]. Mol Cancer Res 2006; 4:27–37.PubMedCrossRefGoogle Scholar
- [14]Land SC, Tee AR. Hypoxia-inducible factor1 {alpha} is regulated by the mammalian target of rapamcin (mTOR) via an mTOR dignaling motif [J]. Bio Chem 2007; 282:20534–20543.CrossRefGoogle Scholar
- [15]Atlas E, Cardillo M, Mehimi I, et al. Heregulin Is Sufficient for the Promotition of Tumorigenicity and Metastasis of Breast Cancer Cells in vito [J]. Mol Cancer Res 2003; 1:165–175.PubMedGoogle Scholar